• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Pharmaceutical Market
Pharmaceutical News
Pharmaceutical Stocks
  • Pharmaceutical Market
  • Pharmaceutical News
  • Pharmaceutical Stocks
pharmaceutical-investing

Cerecor Appoints Interim CEO

Bryan Mc Govern
Aug. 14, 2017 09:15AM PST
Pharmaceutical Investing

Cerecor announced the retirement of its president and CEO Dr. Uli Hacksell.

Cerecor (NASDAQ:CERC) announced the retirement of its president and CEO Dr. Uli Hacksell.
As quoted in the press release:

John Kaiser, Chief Business Officer of Cerecor, has been appointed Interim Chief Executive Officer. Cerecor’s Board of Directors has initiated a search for a permanent Chief Executive Officer. Dr. Hacksell will stay on as Chairman of Cerecor’s Board.
“The recent cash infusions in Cerecor from the equity investment by Armistice Capital in the second quarter of 2017 and the sale of CERC-501 to Janssen that was separately announced today have provided me with the opportunity to leave the day-to-day responsibilities of Cerecor to a new Chief Executive Officer, knowing that I can be optimistic about a bright future for the company,” said Dr. Hacksell. “I will enjoy continuing to participate in guiding the strategic direction of Cerecor as Chairman of the Board.”

Click here to read the full press release.

Source: www.marketwired.com

pharmaceutical-investing board-of-directors john-kaiser
The Conversation (0)

Go Deeper

AI Powered

OKYO Pharma Announces Chairman and Founder Acquires Shares

Thermo Fisher Scientific Elects New Director to Board

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Pharmaceutical Investing Stocks

InMed Pharmaceuticals

InMed Pharmaceuticals (INM)
INM

Cardiol Therapeutics

Cardiol Therapeutics (CRDL:CC)
CRDL:CC
More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES